Cannabis Policy
Hemp Pet Products Recalled Due to High Lead Levels, FDA Announces
A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.
European Commission Considers Reclassifying CBD as a Narcotic
The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.
Rhode Island Licenses its First Medical Cannabis Lab
Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.
US Cannabis Sales Stay Steady
Sales of cannabis have continued to stay at pre-pandemic levels in the US, according to the cannabis market research firm BDSA.
CBD in the UK: Predictions for 2021
For all the excitement, the UK’s CBD industry is actually facing a roadblock, writes Professor Mike Barnes.
Colorado Further Adds to Its List of Acceptable Cannabis Pesticides
The Colorado Department of Agriculture has once again expanded its list of pesticides approved for use on cannabis crops.
Many Dispensaries Still Make “Unsupported Claims” That Cannabis Can Treat Opioid Use Disorder, Says Study
The study found that these claims were more common in US states that listed opioid use disorder as a qualifying condition for medical cannabis.
New Zealand’s Cannabis Legalization Bill Could Do With Some Improvements, Say Addiction Researchers
Before the 'reefer-endum' arrives, the country's legalization bill could still benefit from a few edits, say leading addiction researchers.
Thousands of Cannabis Vape Products Are Still Impounded in Massachusetts
To help decide what to do with the impounded products, state authorities are welcoming input from the public until July 15.
